« Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway ». 2025. Nigerian Journal of Physiological Sciences 40 (2): 251-62. https://doi.org/10.54548/.